ARTICLE | Company News
Jasco Pharmaceuticals, North Carolina Central University deal
March 14, 2011 7:00 AM UTC
The biotech and university will collaborate to develop therapeutics for pancreatic cancer using Jasco's preclinical selective Pim-1 (PIM1), PIM2 and PIM3 kinase inhibitors. Further terms were not d...